Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Buy Us a Coffee
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2022-1274
Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
A flaw was found in Keycloak in the execute-actions-email endpoint. This issue allows arbitrary HTML to be injected into emails sent to Keycloak users and can be misused to perform phishing or other attacks against users.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
Web页面中脚本相关HTML标签转义处理不恰当(基本跨站脚本)
Source: NVD (National Vulnerability Database)
Vulnerability Title
Keycloak 跨站脚本漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Red Hat Keycloak是美国红帽（Red Hat）公司的一套为现代应用和服务提供身份验证和管理功能的软件。 Keycloak存在安全漏洞。攻击者利用该漏洞将任意HTML注入用户的电子邮件中，并对用户进行网络钓鱼或其他攻击。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-keycloak unknown -
II. Public POCs for CVE-2022-1274
#POC DescriptionSource LinkShenlong Link
1Nonehttps://github.com/shoucheng3/keycloak__keycloak_CVE-2022-1274_20-0-3POC Details
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2022-1274
Please Login to view more intelligence information
IV. Related Vulnerabilities
Same product: keycloak
Same vendor: n/a
Same weakness: CWE-80
V. Comments for CVE-2022-1274

No comments yet

Leave a comment